RADIATION · Unmapped registry intervention
89Zr-TLX250 PET/CT
Find medicine records ·
Find other trials using this name
Clinical trial
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NCT06735560
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hepatocellular Carcinoma (HCC)unresolved
Intrahepatic Cholangiocarcinoma (Icc)unresolved
Neuroendocrine Tumorsunresolved
Interventions
89Zr-TLX250 PET/CTRADIATION
Sponsors & collaborators
Nantes University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06735560 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.